Determining the value of antimicrobial surveillance programs

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 4, 2001, Pages 171-175

  Jones, Ronald N ^a,b   Masterton, Robert ^c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial; Meropenem; MYSTIC; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; DRUG USE; HOSPITAL; IN VITRO STUDY; INFECTION CONTROL; MEDICAL PRACTICE; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL;

DRUG RESISTANCE, BACTERIAL; HUMANS; POPULATION SURVEILLANCE; WORLD HEALTH;

EID: 0035681769     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00318-2     Document Type: Conference Paper

References (20)

1. Trends in antibiotic utilization and bacterial resistance report of the National Nosocomial Resistance Surveillance Group
2. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein
3. Beta-lactamases of increasing clinical importance
4. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum β-lactamases
5. Meropenem: A microbiological overview
6. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
7. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996
8. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
9. European surveillance of antibiotic resistance (ESAR), a European Commission funded project
10. Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein
11. Toward multinational antimicrobial resistance surveillance systems in Europe
12. Antibiotic resistance surveillance: How can it be improved?
13. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection). Results from the Americas: Resistance implications in the treatment of serious infections
14. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
15. Reports on surveillance of antimicrobial resistance in individual countries
16. Surveillance of antimicrobial resistance: The WHONET program
17. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection). A global overview
18. The MYSTIC (meropenem yearly susceptibility test information collection) programme